{{medical}}
{{Infobox_Disease
 | Name           = 糖尿病视网膜病变<br/>Diabetic retinopathy 
 | Image          = 
 | Caption        = 
 | DiseasesDB     = 29372
 | ICD10          = {{ICD10|H|36||h|30}} （{{ICD10|E|10|3|e|10}} {{ICD10|E|11|3|e|10}} {{ICD10|E|12|3|e|10}} {{ICD10|E|13|3|e|10}} {{ICD10|E|14|3|e|10}}）
 | ICD9           = {{ICD9|250.5}}
 | ICDO           = 
 | OMIM           = 
 | MedlinePlus    = 000494 
 | MedlinePlus_mult= {{MedlinePlus2|001212}}
 | eMedicineSubj  = oph
 | eMedicineTopic = 414
 | eMedicine_mult = {{eMedicine2|oph|415}}
 | MeshID         = D003930
}}
'''糖尿病视网膜病变'''（英語：Diabetic retinopathy）是[[糖尿病|糖尿病]]的[[并发症|并发症]]。长期的高血糖环境会损伤[[视网膜|视网膜]]血管的内皮，引起一系列的眼底病变，如微血管瘤、硬性渗出、棉絮斑、新生血管、玻璃体增殖、黃班水腫、糖尿病視網膜病變<ref>{{Cite web|title=【陳卓琪眼科醫生】與【高永文醫生】在【獅子會】活動中推廣【糖尿病及相關眼疾】的健康知識|url=http://eyecarehk.org/eyecareaction/%e3%80%90%e9%99%b3%e5%8d%93%e7%90%aa%e7%9c%bc%e7%a7%91%e9%86%ab%e7%94%9f%e3%80%91%e8%88%87%e3%80%90%e9%ab%98%e6%b0%b8%e6%96%87%e9%86%ab%e7%94%9f%e3%80%91%e5%8f%8a%e3%80%90%e6%b8%af%e5%a7%90%e8%ac%9d/|accessdate=2019-08-01|author=|date=2019-06-24|format=|work=睛明護眼 www.EyeCareHK.org|publisher=|language=zh-HK|archive-date=2019-06-28|archive-url=https://web.archive.org/web/20190628194254/http://eyecarehk.org/eyecareaction/%e3%80%90%e9%99%b3%e5%8d%93%e7%90%aa%e7%9c%bc%e7%a7%91%e9%86%ab%e7%94%9f%e3%80%91%e8%88%87%e3%80%90%e9%ab%98%e6%b0%b8%e6%96%87%e9%86%ab%e7%94%9f%e3%80%91%e5%8f%8a%e3%80%90%e6%b8%af%e5%a7%90%e8%ac%9d/|dead-url=no}}</ref>甚至视网膜脱离。一般糖尿病出现十年以上的病人开始出现眼底病变，但如果血糖控制差，或者是胰岛素依赖型糖尿病的患者则可能更早出现眼底病变，故糖尿病患者需要定期到[[眼科学|眼科]]检查眼底。

== 分级 ==
[[File:Eye_disease_simulation,_normal_vision.jpg|thumb]]
[[File:Eye_disease_simulation,_diabetic_retinopathy.jpg|thumb]]
[[File:Retinal_branch_occlusion_ratkaj.jpg|thumb]]
=== 分级 ===
* NPDR：非增殖性糖尿病视网膜病变
* PDR：增殖性糖尿病视网膜病变

=== 单纯性 ===
* I级：有[[微小动脉瘤|微小动脉瘤]]，小出血点。
** （+）：容易数；（++）：太多，数不过来
* Ⅱ级：[[硬性渗出|硬性渗出]]，出血斑
** （+）：容易数；（++）：太多，数不过来
* Ⅲ级：[[软性渗出|软性渗出]]，出血斑
** （+）：容易数；（++）：太多，数不过来

=== 增殖性 ===
* Ⅳ级：新生血管，[[玻璃体出血|玻璃体出血]]
* Ⅴ级：新生血管，纤维增生
* Ⅵ级：新生血管，纤维增生，[[视网膜脱离|视网膜脱离]]


'''診斷''' <ref name="#1">{{Cite web |url=https://www.nejm.org/doi/full/10.1056/NEJMra1909637 |title=存档副本 |access-date=2020-11-15 |archive-date=2020-11-02 |archive-url=https://web.archive.org/web/20201102064826/https://www.nejm.org/doi/full/10.1056/NEJMra1909637 |dead-url=no }}</ref>
* 1. 標準視網膜彩色攝影(standard retinal color photography)：可顯示出1/3視網膜表面(後表面)的血管分布。
* 2. 螢光血管攝影法(fluorescein angiography)：用於判斷血管通透性和血管三層之結構。
* 3. 超寬視野眼底攝影(ultrawide-field photography of the fundus )：可看到80%的視網膜表面，相較標準視網膜彩色攝影，能顯示出更多發生病變的區域。
* 4. 光學相干斷層掃描(Optical coherence tomography, OCT)：非侵入式進行視網膜縱斷面及橫斷面掃描，影像可顯示黃斑中央小凹(fovea)區域是否增厚、不規則，為診斷糖尿病黃斑水腫的好工具。但因無法由OCT判斷視網膜血管內部的微小變化，如血管通透性、血流滲出之強度等，因此需搭配其他血管攝影法進行檢查。
* 5. 自適應光學技術(adaptive optics technology)：如使用雷射式眼底鏡、泛光照明器。這項技術透過可塑形之鏡片偵測視網膜不正常的反射光波，其解像力高，可顯示視網膜上極微小的構造。
* 6. 人工智慧：透過深度學習，人工智慧得以經由影像判讀，辨識視網膜病變區域，並提供相關預後和治療方針。


'''治療''' <ref name="#1"/><ref>{{Cite web |url=https://www.nejm.org/doi/full/10.1056/NEJMra1005073 |title=存档副本 |access-date=2020-11-15 |archive-date=2016-10-07 |archive-url=https://web.archive.org/web/20161007172207/http://www.nejm.org/doi/full/10.1056/NEJMra1005073 |dead-url=no }}</ref>
* 1. 腦垂腺切除術(1970年代以前)
* 2. 泛視網膜雷射 (1970年代至今都有使用)
* 3. 抗血管內皮生長因子(VEGF)抗體：於治療糖尿病黃斑水腫具有一定之成效，如bevacizumab、afibercept已獲得FDA核可。

==延伸閱讀==
{{refbegin}}
*{{cite journal|last1=Solomon|first1=Sharon D.|last2=Chew|first2=Emily|last3=Duh|first3=Elia J.|last4=Sobrin|first4=Lucia|last5=Sun|first5=Jennifer K.|last6=VanderBeek|first6=Brian L.|last7=Wykoff|first7=Charles C.|last8=Gardner|first8=Thomas W.|title=Diabetic Retinopathy: A Position Statement by the American Diabetes Association|journal=Diabetes Care|date=21 February 2017|volume=40|issue=3|pages=412–418|doi=10.2337/dc16-2641|pmid=28223445|pmc=5402875}}
{{refend}}

* Evaluation and Care of Patients with Diabetic Retinopathy
The new England journal of medicine, April 23, 2020 Julie R. Ingelfinger, M.D., Editor 
https://www.nejm.org/doi/full/10.1056/NEJMra1909637 {{Wayback|url=https://www.nejm.org/doi/full/10.1056/NEJMra1909637 |date=20201102064826 }}

* Diabetic Retinopathy 
The new England journal of medicine, March 29, 2012 David A. Antonetti, Ph.D., Ronald Klein, M.D., M.P.H., and Thomas W. Gardner, M.D.
https://www.nejm.org/doi/full/10.1056/NEJMra1005073 {{Wayback|url=https://www.nejm.org/doi/full/10.1056/NEJMra1005073 |date=20161007172207 }}

==外部連結==
{{Medical resources
|  DiseasesDB = 29372 
|  ICD10 = {{ICD10|H|36||h|30}} ({{ICD10|E|10|3|e|10}} {{ICD10|E|11|3|e|10}} {{ICD10|E|12|3|e|10}} {{ICD10|E|13|3|e|10}} {{ICD10|E|14|3|e|10}}) 
|  ICD9 = {{ICD9|250.5}} 
|  ICDO = 
|  OMIM = 
|  MedlinePlus = 000494 
|  eMedicineSubj = oph 
|  eMedicineTopic = 414 
|  eMedicine_mult = {{eMedicine2|oph|415}} 
|  MeshID = D003930
}}
{{commons category}}
* [https://web.archive.org/web/20140512194443/http://www.nei.nih.gov/health/diabetic/retinopathy.asp Diabetic Retinopathy] Resource Guide from the National Eye Institute (NEI).
* [http://diabetes.niddk.nih.gov/ National Diabetes Information Clearinghouse] {{Wayback|url=http://diabetes.niddk.nih.gov/ |date=20100221034416 }}
* [http://diabeticeye.screening.nhs.uk/ NHS Diabetic Eye Screening Programme] {{Wayback|url=http://diabeticeye.screening.nhs.uk/ |date=20150611183340 }}
* [https://web.archive.org/web/20080820181413/http://www.retinalscreening.nhs.uk/ English National Screening Programme for Diabetic Retinopathy]
{{-}}
{{ICD-10-H1}}
{{Endocrine pathology}}
{{Diabetes}}

{{Authority control}}
[[Category:糖尿病|Category:糖尿病]]
[[Category:視覺障礙|Category:視覺障礙]]
[[Category:视网膜疾病|Category:视网膜疾病]]